A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Clinical trial NCT01399125 · COMPLETED
Trial details
- NCT number
- NCT01399125
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-05-01
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.